GALNT1 and neoplasm: Gm56415, also known as polypeptide N-acetylgalactosaminyltransferase 1 (GALNT1), is abnormally expressed in multiple cancers and affects tumor progression by initiating GalNAc-type O-glycosylation of various proteins [22].